Ian Gassiep, Delaney Burnard, Michelle J Bauer, Robert E Norton, Patrick N Harris
Future microbiology 2021 MarMelioidosis is an emerging infectious disease with an estimated global burden of 4.64 million disability-adjusted life years per year. A major determinant related to poor disease outcomes is delay to diagnosis due to the fact that identification of the causative agent Burkholderia pseudomallei may be challenging. Over the last 25 years, advances in molecular diagnostic techniques have resulted in the potential for rapid and accurate organism detection and identification direct from clinical samples. While these methods are not yet routine in clinical practice, laboratory diagnosis of infectious diseases is transitioning to culture-independent techniques. This review article aims to evaluate molecular methods for melioidosis diagnosis direct from clinical samples and discuss current and future utility and limitations.
Ian Gassiep, Delaney Burnard, Michelle J Bauer, Robert E Norton, Patrick N Harris. Diagnosis of melioidosis: the role of molecular techniques. Future microbiology. 2021 Mar;16:271-288
PMID: 33595347
View Full Text